Cargando…
Perturbing the Normal Level of SIDT1 Suppresses the Naked ASO Effect
Although antisense oligonucleotide (ASO) therapeutics can be taken up by living cells without carrier molecules, a large part of incorporated ASOs are trapped in the endosomes and do not exert therapeutic effects. To improve their therapeutic effects, it would be important to elucidate the mechanism...
Autores principales: | Takahashi, Masayuki, Seki, Mineaki, Nashimoto, Masayuki, Kabuta, Tomohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610720/ https://www.ncbi.nlm.nih.gov/pubmed/34824869 http://dx.doi.org/10.1155/2021/2458470 |
Ejemplares similares
-
SIDT2 mediates gymnosis, the uptake of naked single-stranded oligonucleotides into living cells
por: Takahashi, Masayuki, et al.
Publicado: (2017) -
Lysosomal putative RNA transporter SIDT2 mediates direct uptake of RNA by lysosomes
por: Aizawa, Shu, et al.
Publicado: (2016) -
Lysosomal membrane protein SIDT2 mediates the direct uptake of DNA by lysosomes
por: Aizawa, Shu, et al.
Publicado: (2016) -
RNA-hydrolyzing activity of metallo-β-lactamase IMP-1
por: Kato, Yoshiki, et al.
Publicado: (2020) -
Potential physiological roles of the 31/32-nucleotide Y4-RNA fragment in human plasma
por: Ninomiya, Sho, et al.
Publicado: (2019)